Treatment of acute Nipah encephalitis with ribavirin

Nipah virus, a newly identified paramyxovirus caused a severe outbreak of encephalitis in Malaysia with high fatalities. We report an open-label trial of ribavirin in 140 patients, with 54 patients who were managed prior to the availability of ribavirin or refused treatment as control. There were 45...

Full description

Saved in:
Bibliographic Details
Main Authors: Chong, H.T., Kamarulzaman, A., Tan, C.T., Goh, K.J., Thayaparan, T., Kunjapan, R., Chew, N.K., Chua, K.B., Lam, S.K.
Format: Article
Language:English
Published: 2001
Subjects:
Online Access:http://eprints.um.edu.my/4622/1/Chong-2001-Treatment_of_acute_N.pdf
http://eprints.um.edu.my/4622/
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nipah virus, a newly identified paramyxovirus caused a severe outbreak of encephalitis in Malaysia with high fatalities. We report an open-label trial of ribavirin in 140 patients, with 54 patients who were managed prior to the availability of ribavirin or refused treatment as control. There were 45 deaths (32) in the ribavirin arm; 29 deaths (54) occurred in the control arm. This represents a 36 reduction in mortality (p = 0.011). There was no associated serious side effect. This study suggests that ribavirin is able to reduce the mortality of acute Nipah encephalitis.